John Osborn
Member of Board of Directors
Biochemistry
EGALET
Denmark
Biography
Mr. Osborn has been a member of our board of directors since joining in April 2015. An experienced life sciences industry executive, Mr. Osborn was general counsel for a decade with Fortune 1000 biopharmaceutical company Cephalon, Inc. and held senior posts with Onyx Pharmaceuticals, Dendreon, US Oncology and DuPont Merck Pharmaceuticals. He has substantial experience in government affairs and public policy, having served with the U.S. Department of State during the George H.W. Bush administration, and from 2008 to 2011 he was a member of the bipartisan United States Advisory Commission on Public Diplomacy. Mr. Osborn currently is a senior advisor with the international law firm Hogan Lovells, and an industry advisor with the healthcare and consumer group of the global private equity firm Warburg Pincus. He has held faculty appointments at Oxford, Princeton and the University of Washington, and is a member of the Council on Foreign Relations, the American Law Institute, the advisory boards of QPID Health, Inc. and the University of Michigan Life Sciences Institute. Mr. Osborn received his undergraduate degree in economics and history from the University of Iowa, his law degree from the University of Virginia School of Law, and his master’s degree in international public policy from The Johns Hopkins University School of Advanced International Studies.
Research Interest
Biopharmaceutical Biochemistry